Vocal Biomarkers Market, by Therapeutic Application (Psychological Disorders, Respiratory Disorders, and Cardiovascular Disorders), by End User (Hospitals, Health Insurers, Academic & Research Institutions, and Government Organizations), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • Published On : Nov 2019 |
  • Pages : 166 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Vocal Biomarkers Market – Insights

Sound vibrations are used in therapeutic healing for mental health conditions such as depression and anxiety. Recent research has broadened its application for diagnosis of cardiovascular and other diseases.  Biomarkers in the voice of a person have been linked to disorders such as depression, coronary artery disease, and anxiety. Moreover, HIPAA compliant vocal biomarker systems are expected to serve as an effective alternative to current diagnostic techniques such as MRI, X-Ray, and CT scan, owing to successful completion of clinical trials. Research is also underway for identifying vocal biomarkers in the diagnosis of Parkinson’s disease, traumatic brain injury, cognitive impairment, and respiratory disorders, which is expected to offer growth opportunities for market players. Companies operating in the field of voice technology are sampling voice data to provide accurate results. For instance, Beyond Verbal, Inc. has been researching on vocal biomarkers since 1996, and has collected over 2.5 million voice samples in over 40 different languages.

The global vocal biomarkers market size is expected to be valued at US$ 1,357.7 million in 2019, and is expected to exhibit a CAGR of 15.5% over the forecast period (2019 – 2027).

Figure 1. Global Vocal Biomarkers Market Value (US$ Mn), by Region, 2019

Vocal Biomarkers  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of psychological and cardiovascular disease is expected to propel growth of the vocal biomarkers market

Increasing prevalence of psychological and cardiovascular diseases is expected to drive growth of the vocal biomarkers market over the forecast period. For instance, according to the American Stroke Association 2015, cardiovascular disorders was the main cause of death worldwide, accounting for 17.3 Mn deaths per year, which is expected to reach 23.6 Mn by 2030. Moreover, according to the Alzheimer’s Association, in 2017, about 5.5 million people in the U.S suffered from Alzheimer's and dementia, which demands rapid research on biomarkers for early detection of Alzheimer Disease.

Furthermore, vocal biomarker technology systems would act as an ideal cost-effective primary diagnostic tools that could help discern if the patient needs to further opt for expensive X-Ray/MRI/CT/EEG/ECG scans. Thus, many people suffering from these chronic ailments explicates large potential for vocal biomarkers technology in the commercial space in the long run.

Moreover, conventional diagnostic systems need to adhere to stringent regulations concerning to radiation, whereas, the voice-based systems are based on technology that does not use any form of radiation and thus, is expected to gain significant traction over the forecast period.

Figure 2. Global Vocal Biomarkers Market Share (%), by Therapeutic Applications, 2019 and 2027

Vocal Biomarkers  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Rising demand for minimally invasive techniques is expected to drive growth of the vocal biomarkers market

MRI, CT, X-ray, and ECG, are minimally invasive technologies and are out of reach in the emerging economies. Moreover, minimally invasive procedures are preferred by patients due to advantages such as speedy recovery. However, high costs of these techniques results in substantial healthcare burden on the economy.

Key Players

Major players operating in the global vocal biomarkers market include Beyond Verbal, Inc., Sonde Health Inc., Sharecare, Inc., IBM Coporation, and Cogito Corporation

Voice can serve as a useful tool in identifying the presence or risk of conditions such as depression, Parkinson’s disease, and coronary artery disease. Moreover, Research institutes and companies engaged in voice and speech technology are partnering to identify vocal biomarkers that can aid in accurate disease diagnosis. Vocal biomarkers technology could be an advanced innovation in the field of medical diagnostics, allowing for minimally-invasive diagnostic procedures to detect chronic conditions. For instance, Beyond Verbal, Inc., Cogito Corporation, and Sonde Health are developing a voice-based platform to diagnose mental and physical health.

Market Dynamics

The vocal biomarkers technology would transform the way mental and physical health is diagnosed and would transform the healthcare industry. This voice-based technology would allow early diagnosis and preventive treatments. This is expected to benefit hospitals, health clinics, and individuals to monitor health condition and take appropriate medical action.

Key players are focused on collaborations, in order to gain strong foothold in the market and enhance their product portfolio which is expected to drive the market growth. For instance, in June 2016, Sonde Health Inc., obtained technology license from the Massachusetts Institute of Technology Lincoln Laboratory for the latter’s voice-based technology platform intended for monitoring and diagnosing various mental and physical conditions. Moreover, Beyond Verbal, Inc. collaborated with Mayo Clinic in 2016 to conduct studies and identify vocal biomarkers that could help in diagnosing mental and physical health.

Key features of the study:

  • This report provides in-depth analysis of the global vocal biomarkers market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019 – 2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global vocal biomarkers market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Beyond Verbal, Inc., Sonde Health Inc., Sharecare, Inc., IBM Coporation, and Cogito Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics.
  • The global vocal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vocal biomarkers market

Detailed Segmentation:

  • Global Vocal Biomarkers Market, By Therapeutic Application:
    • Psychological Disorders
      • Depression and Anxiety
      • Parkinson’s Disease
      • Cognitive Impairment
      • Other Mental Illnesses
    • Respiratory Disorders
    • Cardiovascular Disorders
  • Global Vocal Biomarkers Market, By End User:
    • Hospitals
    • Health Insurers
    • Academic & Research Institutions
    • Government Organizations
  • Global Vocal Biomarkers Market, By Region:
    • North America
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By  Therapeutic Application:
        • Psychological Disorders
          • Depression and Anxiety
          • Parkinson’s Disease
          • Cognitive Impairment
          • Other Mental Illnesses
        • Respiratory Disorders
        • Cardiovascular Disorders
      • By End User:
        • Hospitals
        • Health Insurers
        • Academic & Research Institutions
        • Government Organizations
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Beyond Verbal, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Sonde Health
    • Sharecare, Inc.
    • IBM Coporation
    • Cogito Corporation

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Therapeutic Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • Epidemiology/Prevalence/Incidence
    • Mergers and Acquisitions Scenario
    • New Product Approvals/Launch
  4. Global Vocal Biomarkers Market, By Therapeutic Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Psychological Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Depression and Anxiety
        • Parkinson’s Disease
        • Cognitive Impairment
        • Other Mental Illnesses
    • Respiratory Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cardiovascular Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Vocal Biomarkers Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Health Insurers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Academic & Research Institutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Government Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Vocal Biomarkers Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Beyond Verbal, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sonde Health Inc.
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sharecare, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • IBM Coporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cogito Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 27 market data tables and 22 figures on "Vocal Biomarkers Market - Global forecast to 2027”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.